Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 12 Similar Profiles
Tuberculosis Medicine & Life Sciences
Mycobacterium tuberculosis Medicine & Life Sciences
HIV Medicine & Life Sciences
Pulmonary Tuberculoses Medicine & Life Sciences
Sputum Medicine & Life Sciences
Infection Medicine & Life Sciences
South Africa Medicine & Life Sciences
Rifampin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2017

Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials

Savic, R. M., Weiner, M., Mackenzie, W. R., Engle, M., Whitworth, W. C., Johnson, J. L., Nsubuga, P., Nahid, P., Nguyen, N. V., Peloquin, C. A., Dooley, K. E. & Dorman, S. E. 2017 In : Clinical Pharmacology and Therapeutics.

Research output: Contribution to journalArticle

Phase II Clinical Trials
Pulmonary Tuberculoses
Pharmacokinetics
Lung
Rifampin

Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance

Manson, A. L. , Cohen, K. A. , Abeel, T. , Desjardins, C. A. , Armstrong, D. T. , Barry, C. E. , Brand, J. , Chapman, S. B. , Cho, S. N. , Gabrielian, A. , Gomez, J. , Jodals, A. M. , Joloba, M. , Jureen, P. , Lee, J. S. , Malinga, L. , Maiga, M. , Nordenberg, D. , Noroc, E. , Romancenco, E. & 27 others Salazar, A., Ssengooba, W., Velayati, A. A., Winglee, K., Zalutskaya, A., Via, L. E., Cassell, G. H., Dorman, S. E., Ellner, J., Farnia, P., Galagan, J. E., Rosenthal, A., Crudu, V., Homorodean, D., Hsueh, P. R., Narayanan, S., Pym, A. S., Skrahina, A., Swaminathan, S., van der Walt, M., Alland, D., Bishai, W. R., Cohen, T., Hoffner, S., Birren, B. W., Earl, A. M. & TBResist Global Genome Consortium Jan 16 2017 In : Nature Genetics.

Research output: Contribution to journalArticle

Multidrug-Resistant Tuberculosis
Multiple Drug Resistance
Mycobacterium tuberculosis
Mutation
Molecular Pathology

In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis

Kaushik, A., Ammerman, N. C., Tasneen, R., Story-Roller, E., Dooley, K. E., Dorman, S. E., Nuermberger, E. L. & Lamichhane, G. Aug 1 2017 In : Journal of Antimicrobial Chemotherapy. 72, 8, p. 2320-2325 6 p., dkx152

Research output: Contribution to journalArticle

Rifampin
Mycobacterium tuberculosis
In Vitro Techniques
Carbapenems
Drug Therapy

Reply to alffenaar et al

Peloquin, C. A., Dorman, S. E., Vernon, A., Migliori, G. B. & Nahid, P. 2017 In : Clinical Infectious Diseases. 64, 1, p. 105-106 2 p.

Research output: Contribution to journalLetter

Serologic Responses in Childhood Pulmonary Tuberculosis

Nonyane, B. A. S., Nicol, M. P., Andreas, N. J., Rimmele, S., Schneiderhan-Marra, N., Workman, L. J., Perkins, M. D., Joos, T., Broger, T., Ellner, J. J., Alland, D., Kampmann, B., Dorman, S. E. & Zar, H. J. Jul 15 2017 In : Pediatric Infectious Disease Journal.

Research output: Contribution to journalArticle

Pulmonary Tuberculoses
Tuberculosis
Antigens
Mycobacterium tuberculosis
Area Under Curve